Equity
€933,135 ▲ 9.0%
PHARM-INTER paid out €230,000 in dividends. That is 75% of the 2025 profit.
PHARM-INTER
Lifetime
20 annual accounts with figures on one time axis, 39 filings since 1987peak €1.2m (2025)
€1.2m▲ 34.4%
lowest -€14,853 (2007)
€307,007▼ 10.9%
peak €933,135 (2025)
€933,135▲ 9.0%
€6.8m▼ 2.3%
peak 4.2 FTE (2019)
3.4 FTEunchanged
Board1 name since 2021
1 director
Documentsfilings and deeds
21-05-202671 days before the deadline
2025financial year
Gross margin from €874,621 to €1.2mDividend €230,000Cash from €1.4m to €3.2m
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,986 companies had the same profile as PHARM-INTER has now. Each dot stands for 10 companies, two years later.
96.4%
were still trading
2.4%
stopped another way
1.1%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,986 companies, not a prediction for PHARM-INTER. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0427154841
Change of role: , from manager to director
Director discharge: · General meeting of 27-10-2023 · Gazette deed
First establishment
PHARMAGROS INTERNATIONAL, Kasteellaan 108, Koekelberg
Comparable companies
same main activity, similar in size and ageThese companies have the same main activity as PHARM-INTER: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €4.2m and €9.5m, founded between 1983 and 1998.
Official details
Source: KBO- Status
- Active since 05-09-1984Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Establishment unit
- 2.036.234.8861081 Koekelberg, since 04-09-1986
- Financial year end
- 31 December
- Peppol
- Reachable since 15-12-2025
Annual accounts 2025
- ≈ €4.9mestimated
- €7.7m▼ 1.1%
- Employeeson 31-12-2025
- 5=
- Filing
- Filed on 21-05-2026, 71 days before the end of the filing period
Insights on PHARM-INTER
PHARM-INTER has existed since 1984. The gross margin grew from €264,707 in 2006 to €1.2m in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PHARM-INTER
- What is the company number of PHARM-INTER?
- The company number of PHARM-INTER is 0427.154.841. The VAT number is the same number with BE in front: BE 0427.154.841.
- Where is PHARM-INTER based?
- The registered office is at Kasteellaan 108, 1081 Koekelberg.Company details
- What does PHARM-INTER do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of PHARM-INTER?
- PHARM-INTER is a private limited company (BV).
- When was PHARM-INTER founded?
- PHARM-INTER was founded on 05-09-1984.
- Is PHARM-INTER still active?
- Yes, PHARM-INTER is an active enterprise in the KBO register.
- How many employees does PHARM-INTER have?
- PHARM-INTER had an average of 3.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of PHARM-INTER?
- The turnover in financial year 2025 is ≈ €4.9m. This figure is estimated from the gross margin of €1.2m and 98 comparable companies (NACE 46). It probably lies between €3.0m and €8.3m.
- Is PHARM-INTER profitable?
- In financial year 2025, PHARM-INTER made a profit of €307,007.
- Where can I find the annual accounts of PHARM-INTER?
- PHARM-INTER filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARM-INTER due?
- PHARM-INTER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.